Macular cystic changes as predictive factor for the recurrence of macular oedema in branch retinal vein occlusion

ConclusionIn BRVO patients treated with anti‐VEGF drugs, the macular cystic changes may be used as an early indicator for impending recurrence of ME, with the decrease in BCVA in the following weeks. These patients should be scheduled for a next visit within 6–8 weeks.

Source: Acta Ophthalmologica - March 6, 2017 Category: Opthalmology Authors: Eric Tilgner, Maiara Dalcegio Favretto, Maria Tuisl, Peter Wiedemann, Matus Rehak Tags: Original Article Source Type: research